The FDA has granted orphan drug designation to Shire’s hemophilia A gene therapy, giving it the boost it needs to catch up with others in the field. Shire specializes in the development of drugs for rare diseases, including hemophilia A …

This awesome article Shire’s Hemophilia Gene Therapy Boosted by Orphan Drug Designation appeared first on Labiotech.eu. Be kind and don’t copy it without asking 😉



Source link